Cargando…

Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma

PURPOSE: To investigate the risk factors for recurrence in patients with early-stage hepatocellular carcinoma (HCC) after minimally invasive treatment with curative intent, then to construct a prediction model based on Lasso-Cox regression and visualize the model built. METHODS: Clinical data were c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Qiao, Wenying, Zhang, Honghai, Liu, Biyu, Li, Jianjun, Zang, Chaoran, Mei, Tingting, Zheng, Jiasheng, Zhang, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726717/
https://www.ncbi.nlm.nih.gov/pubmed/36505501
http://dx.doi.org/10.3389/fimmu.2022.1019638
_version_ 1784844848778444800
author Wang, Qi
Qiao, Wenying
Zhang, Honghai
Liu, Biyu
Li, Jianjun
Zang, Chaoran
Mei, Tingting
Zheng, Jiasheng
Zhang, Yonghong
author_facet Wang, Qi
Qiao, Wenying
Zhang, Honghai
Liu, Biyu
Li, Jianjun
Zang, Chaoran
Mei, Tingting
Zheng, Jiasheng
Zhang, Yonghong
author_sort Wang, Qi
collection PubMed
description PURPOSE: To investigate the risk factors for recurrence in patients with early-stage hepatocellular carcinoma (HCC) after minimally invasive treatment with curative intent, then to construct a prediction model based on Lasso-Cox regression and visualize the model built. METHODS: Clinical data were collected from 547 patients that received minimally invasive treatment in our hospital from January 1, 2012, to December 31, 2016. Lasso regression was used to screen risk factors for recurrence. Then we established Cox proportional hazard regression model and random survival forest model including several parameters screened by Lasso regression. An optimal model was selected by comparing the values of C-index, then the model was visualized and the nomogram was finally plotted. RESULTS: The variables screened by Lasso regression including age, gender, cirrhosis, tumor number, tumor size, platelet-albumin-bilirubin index (PALBI), and viral load were incorporated in the Cox model and random survival forest model (P<0.05). The C-index of these two models in the training sets was 0.729 and 0.708, and was 0.726 and 0.700 in the validation sets, respectively. So we finally chose Lasso-Cox regression model, and the calibration curve in the validation set performed well, indicating that the model built has a better predictive ability. And then a nomogram was plotted based on the model chosen to visualize the results. CONCLUSIONS: The present study established a nomogram for predicting recurrence in patients with early-stage HCC based on the Lasso-Cox regression model. This nomogram was of some guiding significance for screening populations at high risk of recurrence after treatment, by which doctors can formulate individualized follow-up strategies or treatment protocols according to the predicted risk of relapse for patients to improve the long-term prognosis.
format Online
Article
Text
id pubmed-9726717
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97267172022-12-08 Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma Wang, Qi Qiao, Wenying Zhang, Honghai Liu, Biyu Li, Jianjun Zang, Chaoran Mei, Tingting Zheng, Jiasheng Zhang, Yonghong Front Immunol Immunology PURPOSE: To investigate the risk factors for recurrence in patients with early-stage hepatocellular carcinoma (HCC) after minimally invasive treatment with curative intent, then to construct a prediction model based on Lasso-Cox regression and visualize the model built. METHODS: Clinical data were collected from 547 patients that received minimally invasive treatment in our hospital from January 1, 2012, to December 31, 2016. Lasso regression was used to screen risk factors for recurrence. Then we established Cox proportional hazard regression model and random survival forest model including several parameters screened by Lasso regression. An optimal model was selected by comparing the values of C-index, then the model was visualized and the nomogram was finally plotted. RESULTS: The variables screened by Lasso regression including age, gender, cirrhosis, tumor number, tumor size, platelet-albumin-bilirubin index (PALBI), and viral load were incorporated in the Cox model and random survival forest model (P<0.05). The C-index of these two models in the training sets was 0.729 and 0.708, and was 0.726 and 0.700 in the validation sets, respectively. So we finally chose Lasso-Cox regression model, and the calibration curve in the validation set performed well, indicating that the model built has a better predictive ability. And then a nomogram was plotted based on the model chosen to visualize the results. CONCLUSIONS: The present study established a nomogram for predicting recurrence in patients with early-stage HCC based on the Lasso-Cox regression model. This nomogram was of some guiding significance for screening populations at high risk of recurrence after treatment, by which doctors can formulate individualized follow-up strategies or treatment protocols according to the predicted risk of relapse for patients to improve the long-term prognosis. Frontiers Media S.A. 2022-11-23 /pmc/articles/PMC9726717/ /pubmed/36505501 http://dx.doi.org/10.3389/fimmu.2022.1019638 Text en Copyright © 2022 Wang, Qiao, Zhang, Liu, Li, Zang, Mei, Zheng and Zhang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Wang, Qi
Qiao, Wenying
Zhang, Honghai
Liu, Biyu
Li, Jianjun
Zang, Chaoran
Mei, Tingting
Zheng, Jiasheng
Zhang, Yonghong
Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma
title Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma
title_full Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma
title_fullStr Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma
title_full_unstemmed Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma
title_short Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma
title_sort nomogram established on account of lasso-cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726717/
https://www.ncbi.nlm.nih.gov/pubmed/36505501
http://dx.doi.org/10.3389/fimmu.2022.1019638
work_keys_str_mv AT wangqi nomogramestablishedonaccountoflassocoxregressionforpredictingrecurrenceinpatientswithearlystagehepatocellularcarcinoma
AT qiaowenying nomogramestablishedonaccountoflassocoxregressionforpredictingrecurrenceinpatientswithearlystagehepatocellularcarcinoma
AT zhanghonghai nomogramestablishedonaccountoflassocoxregressionforpredictingrecurrenceinpatientswithearlystagehepatocellularcarcinoma
AT liubiyu nomogramestablishedonaccountoflassocoxregressionforpredictingrecurrenceinpatientswithearlystagehepatocellularcarcinoma
AT lijianjun nomogramestablishedonaccountoflassocoxregressionforpredictingrecurrenceinpatientswithearlystagehepatocellularcarcinoma
AT zangchaoran nomogramestablishedonaccountoflassocoxregressionforpredictingrecurrenceinpatientswithearlystagehepatocellularcarcinoma
AT meitingting nomogramestablishedonaccountoflassocoxregressionforpredictingrecurrenceinpatientswithearlystagehepatocellularcarcinoma
AT zhengjiasheng nomogramestablishedonaccountoflassocoxregressionforpredictingrecurrenceinpatientswithearlystagehepatocellularcarcinoma
AT zhangyonghong nomogramestablishedonaccountoflassocoxregressionforpredictingrecurrenceinpatientswithearlystagehepatocellularcarcinoma